Podcasts

Listen to a Pharma Show podcast, which focuses on providing professionals in the pharmaceutical industry with up-to-the-minute information and insights from the experts. View All

• Are Orphan Drugs Still a Licence to Print Money?: Donald Macarthur, global pharmaceutical business analyst talks about Pharma's steps into the orphan drug market and whether payers can afford to fund orphan drugs at a time of austerity measures. Macarthur also shares his insights on how reimbursement rules have affected the market and how risk sharing schemes and patient registries can help bridge the data gap. listen now

  Tags:    Donald Macarthur | pricing | drug pricing 07/21/2011  12:00:00 AM EDT

• Sharpen up on Patient Self-Management Approaches: Soren Skovlund, Director of Patient Research, Advocacy and Support at NovoNordisk, joins Pharma IQ, to discuss best practice approaches to patient education and self management. Firstly Skovlund, talks about how NovoNordisk approaches the issue of patient education and who the key partners are in developing and delivering effective self management programmes in terms of assessment of self-management capacity, collaborative problem identification with patients and patient groups, integrated care planning and motivational techniques. Expanding on this, Skovlund discusses how patient education and self management programmes can deal with patient specific challenges to help deal with problems such as frustration, fatigue, pain and isolation. Next, he looks at how we can gauge the effectiveness of patient education programmes and how NovoNordisk is trying to overcome these difficulties. Finally, he talks about the challenges in implementing self management techniques and the factors which influence patients’ ability to manage their disease. listen now

  Tags:    patient adherence | patient compliance | patient research 05/31/2011  12:00:00 AM EDT

• 30% of Diabetes Patients Admit Skipping Insulin Injections: Patricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems associated with patient adherence to treatment of Type 1 and 2 diabetes, in paediatrics, adolescents and adults. In this exclusive interview, Patricia outlines the origins and remedies of each diabetes type, the development of hypoglycaemia, psychological impact on diabetes sufferers and the ramifications for treatment compliance. listen now

  Tags:    Patricia DeCock | Sanofi Aventis | patient adherence 05/19/2011  12:00:00 AM EDT

• Stumbling Blocks for Patient Compliance in Parkinson’s Disease Treatment: Nicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly experienced patient adherence challenges for Parkinson’s Disease sufferers. He also outlines the best strategy for success in increasing adherence in patients with PD, and highlights the combination of pharmacological and non-pharmacological approaches which works best. Nicolas then elaborates on how he facilitates communications with key stakeholders including patients’ organisations, caregivers and physicians. Furthermore, he explains how best to measure the effectiveness of professional and patient communication to increase the health of patients with PD. Finally, he projects how adherence strategies might evolve as new technologies enable different means and forms of communication with the patient population and other stakeholders. listen now

  Tags:    Nicholas Favre | patient compliance | Lundbeck 05/12/2011  12:00:00 AM EDT

• 8 Social Media Recruiting Strategies for Identifying and Recruiting Top Talent in Healthcare: “Tweet, tweet, tweet…” If a bird is the only thing that comes to mind, then you’ve yet to jump on the social networking bandwagon. Twitter, Facebook and LinkedIn are just a few of the social media tools making their voices heard in the corporate setting, especially in regards to recruitment. With current talent shortages already causing problems in the healthcare industry, and projections indicating that 25 percent of the workforce will be eligible for retirement by 2010 and jumping to 43 percent by 2015, your talent pipeline must be ready to rise to the challenges that lie ahead. Social networking promises to expand your communications capabilities and give you exposure to a pool of readily available talent, creating a cost-effective tool for recruitment and pipeline development. listen now

  Tags:    social media | Steve Wojack | University of Washington Medical Centers 04/13/2011  12:00:00 AM EDT

• Is the European Harmonisation of HTA Worth Pursuing?: Ansgar Hebborn, Head of the Global Payer & HTA Program Policy at F Hoffmann-La Roche, joins Pharma IQ to analyse major trends and implications for the research-based pharmaceutical industry. Firstly he sums up who decides on what constitutes value in the various countries, before discussing how we can align diverging evidentiary standards and expectations of different stakeholders in Europe and beyond. He also talks about the new German attempt to implement its version of "value-based pricing" and how thiscompares to VB progress in the UK. Finally, he comments on whether we need relative efficacy/ effectiveness assessments, whether there is truly a central role for EMA and if harmonisation of HTA is worth pursuing. listen now

  Tags:    Ansgar Hebborn | F Hoffmann-La Roche | HTA 02/23/2011  12:00:00 AM EST

• Spearheading Economically Sustainable Scientific Strategies for Cancer: Prof. Dr. Ahmed Elzawawy, President of International Campaign for Establishment and Development of Oncology Centres (ICEDOC) & Co-President of South and East Mediterranean College of Oncology (SEMCO), speaks about the challenges for cancer management facilities in low and middle income countries, the Win-Win Initiative and need for more economically sustainable strategies for cancer. listen now

  Tags:    Ahmed Elzawawy | oncology | Cancer 01/12/2011  12:00:00 AM EST

• Trying to Stay Cool: Canadian Pharmacy Players Under Pressure from Changes to Generic Pricing: “With of reduction in payments there are more mergers and acquisitions. Second of all, there is more vertical integration by the wholesalers into the retail sector. We have had retail actually starting to do more of their own distribution as a trend just recently in Canada,” said Joe Knott, Managing Director of the Pangaea Group. In this Pharma IQ interview Joe Knott discusses the impact of recent dramatic changes to the Canadian drug distribution market. He also shares his top tips for a company choosing a distribution model and his insights on how stakeholders in the supply chain can work better together. listen now

  Tags:    Joe Knott | Pangaea Group | Canadian drug distribution market 12/08/2010  12:00:00 AM EST

• What is the Goal of the Budni-Partner-Pharmacies Project?: In this German-speaking interview, Jens Apermann, CEO of Iwan Budnikowsky Marketing GmbH, gives insight into his company’s marketing and selling of non-prescription pharmaceutical products outside the traditional German pharmacy setting. listen now

  Tags:    Jens Apermann | pharmacy | non-prescription pharmaceutical products 09/23/2010  12:00:00 AM EDT